When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALBO - Albireo up 10% ahead of late-stage odevixibat data readout
Albireo Pharma Inc.
Thinly traded micro cap Albireo Pharma (NASDAQ:ALBO) perks up 10% premarket on light volume ahead of this morning's conference call (8:30 am ET) to discuss topline results from a Phase 3 clinical trial, PEDFIC 1, evaluating lead candidate odevixibat in patients with a rare inherited disorder called progressive familial intrahepatic cholestasis (PFIC) in which liver cells are unable to secrete bile due to mutations in a gene the encodes a protein that plays a key role in bile acid homeostasis (stable equilibrium).
More news on: Albireo Pharma, Inc., Healthcare stocks news, Stocks on the move,